Related Experiment Videos
[PPI very long-term treatment: is the problem only economic?]
1Département de Médecine générale, Université de Liège, Belgique. marc.vanmeerbeek@ulg.ac.be
Revue Medicale De Liege
|August 17, 2006
Summary
Proton pump inhibitors (PPIs) are effective for gastroesophageal reflux disease, offering superior efficacy and established safety over H2-receptor antagonists. Optimal dosing and patient selection are key for cost-effective management.
Area of Science:
- Gastroenterology
- Pharmacology
Context:
- Proton pump inhibitors (PPIs) are widely prescribed in Belgium for gastroesophageal reflux disease (GERD).
- GERD significantly impacts health-related well-being.
- High prevalence of GERD necessitates effective treatment strategies.
Purpose:
- To evaluate the efficacy, safety, and cost-effectiveness of PPIs in managing GERD.
- To provide guidance on appropriate PPI prescribing practices.
- To compare PPIs with H2-receptor antagonists and other treatment options.
Summary:
- PPIs demonstrate superior short-term and long-term efficacy compared to H2-receptor antagonists, with established long-term safety.
- Empirical short-term PPI treatment is acceptable for younger patients without alarm signs, but endoscopy is crucial before long-term therapy.
- Dosing should be tailored to individual response, with continuous full-dose maintenance recommended for severe esophagitis. Lifestyle advice remains valuable.
Impact:
- Optimizing PPI use can ensure cost-effectiveness for healthcare systems.
- This guidance supports appropriate prescribing of PPIs, balancing efficacy with patient outcomes.
- Highlights the importance of diagnostic procedures and individualized treatment plans for GERD management.
Related Concept Videos
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26Methods of Documentation II: POMR
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...